PRESS RELEASE published on 10/27/2025 at 22:15, 1 month 8 days ago Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited closes non-brokered private placement, issuing 1,428,570 units for gross proceeds of $2,000,000. Funds to be used for corporate purposes and cancer research. Statutory hold period applies to securities issued Private Placement Securities Cancer Research Statutory Hold Period Onco-Innovations Limited
BRIEF published on 10/15/2025 at 02:05, 1 month 21 days ago Onco-Innovations annonce un placement privé de 2 millions de dollars Placement Privé Mandats Approbation Réglementaire Onco-Innovations Christophe Gulka
BRIEF published on 10/15/2025 at 02:05, 1 month 21 days ago Onco-Innovations Announces $2 Million Private Placement Private Placement Warrants Regulatory Approval Onco-Innovations Christopher Gulka
PRESS RELEASE published on 10/15/2025 at 02:00, 1 month 21 days ago Onco-Innovations Announces Private Placement Onco-Innovations Limited announces non-brokered private placement of up to $2,000,000 and appointment of Mr. Christopher Gulka to the Board of Directors Board Of Directors Private Placement Appointment Onco-Innovations Limited Christopher Gulka
BRIEF published on 09/29/2025 at 06:05, 2 months 6 days ago Onco-Innovations et Nucro-Technics lancent le programme préclinique PNKP Etudes Précliniques Onco-Innovations Technologie PNKP Nucro-Techniques Développement Analytique
BRIEF published on 09/29/2025 at 06:05, 2 months 6 days ago Onco-Innovations and Nucro-Technics Initiate Preclinical PNKP Program Preclinical Studies Onco-Innovations PNKP Technology Nucro-Technics Analytical Development
PRESS RELEASE published on 09/29/2025 at 06:00, 2 months 6 days ago Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS Preclinical Onco-Innovations PNKP Technology Nucro-Technics Analytical Methods
BRIEF published on 09/22/2025 at 23:05, 2 months 12 days ago Onco-Innovations Appoints Dr. Michael Lock to Advisory Board Cancer Research Onco-Innovations PNKP Inhibitor Clinical Advisory Board Dr. Michael Lock
BRIEF published on 09/22/2025 at 23:05, 2 months 12 days ago Onco-Innovations nomme le Dr Michael Lock au conseil consultatif Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dr Michael Lock Conseil Consultatif Clinique
PRESS RELEASE published on 09/22/2025 at 23:00, 2 months 12 days ago Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board Onco-Innovations appoints Dr. Michael Lock, an expert in oncology and clinical trial design, to its Advisory Board. The company also grants RSUs to key personnel Cancer Research RSUs Onco-Innovations Dr. Michael Lock Clinical Trial Design
Published on 12/05/2025 at 14:00, 30 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 30 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 55 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 13 hours 30 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/05/2025 at 14:16, 13 minutes ago Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 19 minutes ago The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 44 minutes ago BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 30 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 30 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 13:58, 31 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 5 hours 45 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 5 hours 45 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 5 hours 47 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 15 minutes ago Résiliation d'une convention conclue entre actionnaires